Literature DB >> 9396683

Inhibitory effect of macrolides on interleukin-8 secretion from cultured human nasal epithelial cells.

H Suzuki1, A Shimomura, K Ikeda, M Furukawa, T Oshima, T Takasaka.   

Abstract

The mechanism of macrolide therapy in chronic sinusitis patients is unclear. The authors studied the effect of macrolides on interleukin (IL)-8 secretion from cultured human nasal epithelial cells. Epithelial cells harvested from the nasal polyps of patients with chronic sinusitis were primary-cultured, and secreted IL-8 in culture media was measured by enzyme immunoassay. The cells secreted considerable amounts of IL-8 constitutively and in response to lipopolysaccharide. The secretion was significantly inhibited by 10(-5) M of erythromycin, clarithromycin, roxithromycin, and josamycin. 10(-6) M erythromycin still showed the inhibitory effect, whereas the same concentration of josamycin did not. These results indicate that macrolide antibiotics may act as an immunomodulator to reduce IL-8 in inflammatory sites and, at least partially, account for the clinically discrepant effects between 14- and 16-membered ring macrolides in long-term low-dose therapy for chronic sinusitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396683     DOI: 10.1097/00005537-199712000-00016

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  21 in total

Review 1.  Lung transplantation: opportunities for research and clinical advancement.

Authors:  David S Wilkes; Thomas M Egan; Herbert Y Reynolds
Journal:  Am J Respir Crit Care Med       Date:  2005-07-14       Impact factor: 21.405

2.  Effect of 14-membered-ring macrolides on production of interleukin-8 mediated by protease-activated receptor 2 in human keratinocytes.

Authors:  Tatsuya Tsuda; Chika Ishikawa; Hiroe Konishi; Yoshiaki Hayashi; Noboru Nakagawa; Masato Matsuki; Hitoshi Mizutani; Kiyofumi Yamanishi
Journal:  Antimicrob Agents Chemother       Date:  2008-01-22       Impact factor: 5.191

Review 3.  The Role of Macrolides in Chronic Rhinosinusitis (CRSsNP and CRSwNP).

Authors:  Gretchen M Oakley; Richard J Harvey; Valerie J Lund
Journal:  Curr Allergy Asthma Rep       Date:  2017-05       Impact factor: 4.806

4.  Macrolide therapy for chronic rhinosinusitis: a meta-analysis.

Authors:  Melissa A Pynnonen; Giri Venkatraman; Greg E Davis
Journal:  Otolaryngol Head Neck Surg       Date:  2013-01-11       Impact factor: 3.497

Review 5.  Cystic fibrosis chronic rhinosinusitis: a comprehensive review.

Authors:  Mohamad R Chaaban; Alexandra Kejner; Steven M Rowe; Bradford A Woodworth
Journal:  Am J Rhinol Allergy       Date:  2013 Sep-Oct       Impact factor: 2.467

Review 6.  Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.

Authors:  Anders Cervin; Ben Wallwork
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

Review 7.  Mechanisms of action and clinical application of macrolides as immunomodulatory medications.

Authors:  Soichiro Kanoh; Bruce K Rubin
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 8.  Pathogenesis and management of nasal polyposis in cystic fibrosis.

Authors:  Jochen G Mainz; Assen Koitschev
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

Review 9.  Anti-inflammatory therapies for cystic fibrosis-related lung disease.

Authors:  David P Nichols; Michael W Konstan; James F Chmiel
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

10.  The Value of Macrolide-Based Regimens for Community-Acquired Pneumonia.

Authors:  Alexandra McFarlane; Wendy Sligl
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.